Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Labcorp announces $0.72 dividend per share

EditorEmilio Ghigini
Published 12/01/2024, 13:58
© Reuters.
LH
-

BURLINGTON, N.C. - Laboratory Corporation of America Holdings (NYSE: NYSE:LH), commonly known as Labcorp, has declared a quarterly cash dividend of $0.72 per share on its common stock. The dividend is scheduled to be paid on March 13, 2024, to shareholders who are on the record by the close of business on February 27, 2024.

Labcorp is recognized as a prominent player in the life sciences industry, providing a range of laboratory services that support physicians, hospitals, pharmaceutical entities, researchers, and patients. The company's services are designed to deliver clear insights and foster advancements in science for the enhancement of health and lives. Labcorp's operations encompass diagnostics and drug development laboratory services that contribute to the healthcare landscape.

The company is noted for its significant role in the healthcare industry, with a workforce exceeding 60,000 employees and a service reach spanning over 100 countries. According to the company's statement, Labcorp was involved in the development of over 80% of the new drugs approved by the FDA in 2022 and conducted more than 600 million tests for patients globally.

Labcorp's announcement is based on a press release statement and is intended to inform shareholders and the broader financial community of the upcoming dividend payment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.